By leveraging AI in tandem with representative data, the Hub will become a global center of excellence in drug, vaccine, and diagnostics development. It will address the unique needs of underrepresented patient segments, improve diagnostic accuracy and drug efficacy, reduce
timelines to develop new drugs and vaccines, enable rapid response to emerging health threats, and improve health outcomes of diverse patients at home and abroad.
Comments